This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Pharmacodynamic optimization of β-lactams in the patient care setting
-
Correspondence: David P Nicolau dnicola@harthosp.org
Critical Care 2008, 12(Suppl 4):S2 doi:10.1186/cc6818
Accesses
- Last 30 days: 163 accesses
- Last 365 days: 2059 accesses
- All time: 9923 accesses
Cited by
BioMed Central: 1 citation
|
Introduction
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance Reuben Ramphal Critical Care 2008, 12(Suppl 4):S1 (21 May 2008) |
